Instituto Rosenbusch S.A. (ROSE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Instituto Rosenbusch S.A. (ROSE) has a cash flow conversion efficiency ratio of -1.542x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AR$811.18 Million ≈ $586.98K USD) by net assets (AR$-526.19 Million ≈ $-380.75K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Instituto Rosenbusch S.A. for the company's overall valuation and market capitalisation.
Instituto Rosenbusch S.A. - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Instituto Rosenbusch S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Instituto Rosenbusch S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Instituto Rosenbusch S.A. ranked by their cash flow conversion efficiency. Explore Instituto Rosenbusch S.A. (ROSE) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
NASDAQ:HKPD
|
-0.053x |
|
BuilderSmart Public Company Limited
BK:BSM
|
0.083x |
|
IQE PLC
LSE:IQE
|
0.005x |
|
Custodian REIT PLC
LSE:CREI
|
0.025x |
|
Jowell Global Ltd.
NASDAQ:JWEL
|
-0.494x |
|
Binect AG
XETRA:MA10
|
0.012x |
|
Massivit 3D Printing Technologies Ltd
TA:MSVT
|
-0.392x |
|
Wishpond Technologies Ltd
V:WISH
|
-0.061x |
Annual Cash Flow Conversion Efficiency for Instituto Rosenbusch S.A. (2000–2025)
The table below shows the annual cash flow conversion efficiency of Instituto Rosenbusch S.A. from 2000 to 2025. View Instituto Rosenbusch S.A. share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | AR$-526.19 Million ≈ $-380.75K |
AR$409.89 Million ≈ $296.60K |
-0.779x | -531.50% |
| 2024-12-31 | AR$3.99 Billion ≈ $2.89 Million |
AR$720.31 Million ≈ $521.22K |
0.181x | +147.75% |
| 2023-12-31 | AR$4.55 Billion ≈ $3.29 Million |
AR$331.37 Million ≈ $239.78K |
0.073x | -40.74% |
| 2022-12-31 | AR$400.51 Million ≈ $289.81K |
AR$49.25 Million ≈ $35.64K |
0.123x | -58.04% |
| 2021-12-31 | AR$199.19 Million ≈ $144.13K |
AR$58.37 Million ≈ $42.24K |
0.293x | -34.20% |
| 2020-12-31 | AR$147.69 Million ≈ $106.87K |
AR$65.78 Million ≈ $47.60K |
0.445x | -13.10% |
| 2019-12-31 | AR$115.52 Million ≈ $83.59K |
AR$59.20 Million ≈ $42.84K |
0.513x | +439.11% |
| 2018-12-31 | AR$145.95 Million ≈ $105.61K |
AR$-22.06 Million ≈ $-15.96K |
-0.151x | -272.55% |
| 2017-12-31 | AR$86.58 Million ≈ $62.65K |
AR$-3.51 Million ≈ $-2.54K |
-0.041x | -121.32% |
| 2016-12-31 | AR$83.24 Million ≈ $60.23K |
AR$15.84 Million ≈ $11.46K |
0.190x | +252.20% |
| 2015-12-31 | AR$70.62 Million ≈ $51.10K |
AR$-8.83 Million ≈ $-6.39K |
-0.125x | -192.60% |
| 2014-12-31 | AR$68.24 Million ≈ $49.38K |
AR$9.21 Million ≈ $6.67K |
0.135x | -32.36% |
| 2011-12-31 | AR$56.25 Million ≈ $40.70K |
AR$11.23 Million ≈ $8.12K |
0.200x | +96.02% |
| 2010-12-31 | AR$50.20 Million ≈ $36.32K |
AR$5.11 Million ≈ $3.70K |
0.102x | +352.72% |
| 2009-12-31 | AR$46.95 Million ≈ $33.97K |
AR$1.06 Million ≈ $764.13 |
0.022x | -87.71% |
| 2008-12-31 | AR$45.65 Million ≈ $33.03K |
AR$8.36 Million ≈ $6.05K |
0.183x | +811.58% |
| 2007-12-31 | AR$37.50 Million ≈ $27.13K |
AR$753.00K ≈ $544.87 |
0.020x | -65.96% |
| 2006-12-31 | AR$35.97 Million ≈ $26.03K |
AR$2.12 Million ≈ $1.54K |
0.059x | -61.58% |
| 2005-12-31 | AR$34.13 Million ≈ $24.70K |
AR$5.24 Million ≈ $3.79K |
0.154x | -9.98% |
| 2003-12-31 | AR$28.27 Million ≈ $20.45K |
AR$4.82 Million ≈ $3.49K |
0.171x | +122.37% |
| 2002-12-31 | AR$24.17 Million ≈ $17.49K |
AR$1.85 Million ≈ $1.34K |
0.077x | +268.10% |
| 2000-12-31 | AR$11.90 Million ≈ $8.61K |
AR$248.00K ≈ $179.45 |
0.021x | -- |
About Instituto Rosenbusch S.A.
Instituto Rosenbusch S.A. manufactures and sells veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious kera… Read more